APA (7th ed.) Citation

Aspite, S., Schepis, F., Roccarina, D., Gitto, S., Citone, M., Di Bonaventura, C., . . . Vizzutti, F. (2022). Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status. Liver International, 42(2), 419. https://doi.org/10.1111/liv.15148

Chicago Style (17th ed.) Citation

Aspite, Silvia, et al. "Portosystemic Shunt Is an Effective Treatment for Complications of Portal Hypertension in Hepatic Myeloid Metaplasia and Improves Nutritional Status." Liver International 42, no. 2 (2022): 419. https://doi.org/10.1111/liv.15148.

MLA (9th ed.) Citation

Aspite, Silvia, et al. "Portosystemic Shunt Is an Effective Treatment for Complications of Portal Hypertension in Hepatic Myeloid Metaplasia and Improves Nutritional Status." Liver International, vol. 42, no. 2, 2022, p. 419, https://doi.org/10.1111/liv.15148.